Delivery Order SPE2DB20D9135-SPE2DB22FD3BC

Award Date 6/9/22
Potential Completion Date 7/1/22
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $35,995.44, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of BOTOX 100 unit vials, with a period of performance through November 4, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This federal contract award is for the delivery of BOTOX 100 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency, under a firm fixed-price delivery order. The contract, valued at $46,148.00, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a total potential...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,922.20 firm fixed-price delivery order is for the supply of 100-unit vials of Botox. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a...
This federal contract award is for the delivery of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency. The $9,181.00 fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has an ultimate completion date of March 31, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of BOTOX 100 unit vials to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) through the Medical Supply Chain program of the Defense Logistics Agency (DLA). The $48,455.40 firm fixed-price delivery order (SPE2DX24F6ACB) was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has an ultimate completion date of October 16, 2024 and does not utilize a set-aside...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,356.60, is for the delivery of 200 unit vials of Botox. This award is under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a wide range of pharmaceutical...
This federal contract award, valued at $31,708.00, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4557272039 - BOTOX 200 UNIT VIALS. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract, valued at $44,087.00, is to provide BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DLA and DMS Pharmaceutical Group,...
This federal contract award is for the delivery of BOTOX 100 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $48,569.85 and an ultimate completion date of April 15, 2025. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group...
This federal contract award is for the delivery of BOTOX 100 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $88,144.00 and is a firm fixed-price delivery order with no set-aside designation. This award is part of DMS Pharmaceutical Group's broader contractual relationship...
  • SPE2DB20D9135
    Indefinite Delivery Contract
  • SPE2DB20D9135-SPE2DB22FD3BC
    Delivery Order

This federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The $5,085.28 firm fixed-price delivery order was awarded on June 9, 2022 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that provides a wide range of medications and medical supplies to support the recurring needs of military health facilities. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for various pharmaceutical items. The contract does not have a set-aside designation.

Generated 1/9/25, 9:11 AM